Nurix Therapeutics (NRIX)
(Delayed Data from NSDQ)
$14.13 USD
+0.32 (2.32%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $14.12 -0.01 (-0.07%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
07/11/2024
Time: -- |
5/2024 | $-0.72 | 3.50% |
Earnings Summary
For their last quarter, Nurix Therapeutics (NRIX) reported earnings of -$0.76 per share, beating the Zacks Consensus Estimate of $-0.80 per share. This reflects a positive earnings surprise of 5.00%. Look out for NRIX's next earnings release expected on July 11, 2024. For the next earning release, we expect the company to report earnings of -$0.72 per share, reflecting a year-over-year decrease of 60%.
Earnings History
Price & Consensus
Zacks News for NRIX
ALX Oncology (ALXO) Posts Upbeat Results From Lymphoma Study
NRIX: What are Zacks experts saying now?
Zacks Private Portfolio Services